Eleven Therapeutics
unknown
unknown
Stage
1
Investors
About
Eleven Therapeutics develops next-generation RNA therapeutics and an AI-driven design platform (xRNA) that applies massively-parallel combinatorial chemistry, sequencing, and big-data methods to map RNA chemical space and optimize structure-activity relationships for safety, efficiency, and duration of effect.
Explore Eleven Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.